Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00589095 · ClinicalTrials.gov registry record
Early Detection of Glioblastoma Multiforme (GBM) Treatment Responses Using Multiple Magnetic Resonance Modalities
A clinical trial, sponsored by Yale University.
- Terminated
- Registry status
- 5
- Enrollment target
NCT00589095: Clinical Trial study, sponsored by Yale University.
NCT00589095 is a clinical trial that was terminated before completion, run by Yale University. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00589095 was terminated before completion, sponsored by Yale University.
- TERMINATED
- Registry status
- 5 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether dynamic contrast enhanced MRI (DCE MRI) and high diffusion weighting MRI may be used to distinguish between favorable and unfavorable responses to therapy of glioblastoma multiforme. Imaging data will be correlated with histopathologic findings and clinical responses to radiation therapy with or without chemotherapy.
Interventions
- OTHER dynamic contrast enhanced magnetic resonance imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2006-11 |
| Est. Completion | 2011-08 |
Why NCT00589095 stopped before completion
NCT00589095 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 5 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which dynamic contrast enhanced magnetic resonance imaging is the first listed.
NCT00589095 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00589095 about?
NCT00589095 is a clinical study titled "Early Detection of Glioblastoma Multiforme (GBM) Treatment Responses Using Multiple Magnetic Resonance Modalities". The purpose of this study is to determine whether dynamic contrast enhanced MRI (DCE MRI) and high diffusion weighting MRI may be used to distinguish between favorable and unfavorable responses to therapy of glioblastoma multiforme. Imaging data will be correlated with histopathologic findings and c...
What is the current status of trial NCT00589095?
This trial is currently terminated. The enrollment target is 5 participants. The study started on 2006-11. Estimated completion is 2011-08.
What interventions are being tested in trial NCT00589095?
The interventions under investigation include: dynamic contrast enhanced magnetic resonance imaging (OTHER).
Who is sponsoring clinical trial NCT00589095?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia